Cross-Species Transcriptional Network Analysis Defines Shared Inflammatory Responses in Murine and Human Lupus Nephritis

Lupus nephritis (LN) is a serious manifestation of systemic lupus erythematosus. Therapeutic studies in mouse LN models do not always predict outcomes of human therapeutic trials, raising concerns about the human relevance of these preclinical models. In this study, we used an unbiased transcriptional network approach to define, in molecular terms, similarities and differences among three lupus models and human LN. Genome-wide gene-expression networks were generated using natural language processing and automated promoter analysis and compared across species via suboptimal graph matching. The three murine models and human LN share both common and unique features. The 20 commonly shared network nodes reflect the key pathologic processes of immune cell infiltration/activation, endothelial cell activation/injury, and tissue remodeling/fibrosis, with macrophage/dendritic cell activation as a dominant cross-species shared transcriptional pathway. The unique nodes reflect differences in numbers and types of infiltrating cells and degree of remodeling among the three mouse strains. To define mononuclear phagocyte-derived pathways in human LN, gene sets activated in isolated NZB/W renal mononuclear cells were compared with human LN kidney profiles. A tissue compartment-specific macrophage-activation pattern was seen, with NF-κB1 and PPARγ as major regulatory nodes in the tubulointerstitial and glomerular networks, respectively. Our study defines which pathologic processes in murine models of LN recapitulate the key transcriptional processes active in human LN and suggests that there are functional differences between mononuclear phagocytes infiltrating different renal microenvironments.

[1]  Eric Thervet,et al.  Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. , 2002, Kidney international.

[2]  S. Segerer,et al.  Dendritic Cells in Human Renal Inflammation – Part II , 2011, Nephron Experimental Nephrology.

[3]  J. Duffield Macrophages and immunologic inflammation of the kidney. , 2010, Seminars in nephrology.

[4]  T. Utset,et al.  Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring , 2011, Arthritis care & research.

[5]  L. Davis,et al.  Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus. , 2010, Arthritis and rheumatism.

[6]  E. Bottinger,et al.  Activated Renal Macrophages Are Markers of Disease Onset and Disease Remission in Lupus Nephritis1 , 2008, The Journal of Immunology.

[7]  C. Cohen,et al.  Compartment specific expression of dendritic cell markers in human glomerulonephritis. , 2008, Kidney international.

[8]  Xuejun Liu,et al.  Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. , 2004, The Journal of clinical investigation.

[9]  D. Ferenbach,et al.  Macrophages and dendritic cells: what is the difference? , 2008, Kidney international.

[10]  Felix Eichinger,et al.  Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.

[11]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[12]  M. Madaio,et al.  Short Term Administration of Costimulatory Blockade and Cyclophosphamide Induces Remission of Systemic Lupus Erythematosus Nephritis in NZB/W F1 Mice by a Mechanism Downstream of Renal Immune Complex Deposition , 2003, The Journal of Immunology.

[13]  R. Evans,et al.  PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.

[14]  G. Müller-Newen,et al.  J Am Soc Nephrol 15: 613–621, 2004 Identification and Functional Characterization of Dendritic Cells in the Healthy Murine Kidney and in Experimental , 2003 .

[15]  M. Ward Changes in the Incidence of Endstage Renal Disease Due to Lupus Nephritis in the United States, 1996–2004 , 2008, The Journal of Rheumatology.

[16]  M. Ward Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. , 2000, Archives of internal medicine.

[17]  E. Bottinger,et al.  Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis , 2008, The Journal of Immunology.

[18]  E. Meffre,et al.  In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis , 2011, The Journal of Immunology.

[19]  M. Madaio,et al.  Prevention of murine antiphospholipid syndrome by BAFF blockade. , 2008, Arthritis and rheumatism.

[20]  C. Cerletti,et al.  Src-family kinases mediate an outside-in signal necessary for beta2 integrins to achieve full activation and sustain firm adhesion of polymorphonuclear leucocytes tethered on E-selectin. , 2006, The Biochemical journal.

[21]  C. Mohan,et al.  Systemic lupus erythematosus--recent clues from congenic strains. , 2005, Archivum immunologiae et therapiae experimentalis.

[22]  D. Gladman,et al.  Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. , 2000, The Journal of rheumatology.

[23]  W. Liang,et al.  TM4 microarray software suite. , 2006, Methods in enzymology.

[24]  P. Igarashi,et al.  CXCR4/CXCL12 Hyperexpression Plays a Pivotal Role in the Pathogenesis of Lupus1 , 2009, The Journal of Immunology.

[25]  S. Adler,et al.  Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[26]  A. Theofilopoulos,et al.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains , 1978, The Journal of experimental medicine.

[27]  A. Piccoli,et al.  Long-term prognosis and causes of death in systemic lupus erythematosus. , 2006, The American journal of medicine.

[28]  Sik Lee,et al.  Distinct macrophage phenotypes contribute to kidney injury and repair. , 2011, Journal of the American Society of Nephrology : JASN.

[29]  W. Liang,et al.  9) TM4 Microarray Software Suite , 2006 .

[30]  B. Hoffman,et al.  Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation , 2002, Oncogene.

[31]  M. Rastaldi,et al.  The Detrimental Effects of IFN-α on Vasculogenesis in Lupus Are Mediated by Repression of IL-1 Pathways: Potential Role in Atherogenesis and Renal Vascular Rarefaction , 2010, The Journal of Immunology.

[32]  Jignesh M. Patel,et al.  TALE: A Tool for Approximate Large Graph Matching , 2008, 2008 IEEE 24th International Conference on Data Engineering.

[33]  Michael Loran Dustin,et al.  CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. , 2006, Kidney international.

[34]  L. Fésüs,et al.  PPARγ‐dependent regulation of human macrophages in phagocytosis of apoptotic cells , 2007, European journal of immunology.

[35]  Yutaka Kobayashi,et al.  Quantitative analysis of interstitial alterations in lupus nephritis , 2004, Virchows Archiv A.

[36]  F. Dekker,et al.  Survival Analysis I: The Kaplan-Meier Method , 2011, Nephron Clinical Practice.

[37]  C. Mohan,et al.  Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus , 2009, Expert opinion on therapeutic targets.

[38]  S. McMahon,et al.  Emerging Concepts in the Analysis of Transcriptional Targets of the MYC Oncoprotein: Are the Targets Targetable? , 2010, Genes & cancer.

[39]  Ziv Bar-Joseph,et al.  Cross Species Expression Analysis of Innate Immune Response , 2009, J. Comput. Biol..

[40]  V. D’Agati,et al.  Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. , 1986, Nephron.

[41]  M. Rastaldi,et al.  Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy , 2009, Diabetes.

[42]  J. Grande Experimental models of lupus nephritis. , 2011, Contributions to nephrology.

[43]  B. J. Helyer,et al.  Renal Disease associated with Positive Lupus Erythematosus Tests in a Crossbred Strain of Mice , 1963, Nature.

[44]  S. Segerer,et al.  Dendritic Cells in Experimental Renal Inflammation – Part I , 2011, Nephron Experimental Nephrology.

[45]  A. DeFranco,et al.  Fcγ Receptor–Mediated Phagocytosis in Macrophages Lacking the Src Family Tyrosine Kinases Hck, Fgr, and Lyn , 2000, The Journal of experimental medicine.

[46]  Michael L. Creech,et al.  Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.

[47]  E. Bottinger,et al.  A Unique Hybrid Renal Mononuclear Phagocyte Activation Phenotype in Murine Systemic Lupus Erythematosus Nephritis , 2011, The Journal of Immunology.

[48]  D. Sanoudou,et al.  Regulation of adverse remodelling by osteopontin in a genetic heart failure model. , 2012, European heart journal.

[49]  C. Cohen,et al.  Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. , 2002, Kidney international.

[50]  T. Yamamoto,et al.  Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. , 2000, Journal of immunology.

[51]  A. Davidson,et al.  Targeting of the immune system in systemic lupus erythematosus , 2008, Expert Reviews in Molecular Medicine.

[52]  A. Davidson,et al.  Lupus nephritis: lessons from murine models , 2010, Nature Reviews Rheumatology.

[53]  K. Walsh,et al.  The Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Ameliorates Murine Lupus by Induction of Adiponectin1 , 2009, The Journal of Immunology.

[54]  B. Staels,et al.  Regulation of Macrophage Functions by PPAR-&agr;, PPAR-&ggr;, and LXRs in Mice and Men , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[55]  T. Kawakami,et al.  Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5. , 2008, The Journal of clinical investigation.

[56]  M. Madaio,et al.  Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice. , 2010, Arthritis and rheumatism.

[57]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[58]  R. Cantor,et al.  Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus , 2010, Proceedings of the National Academy of Sciences.

[59]  K. Coombes,et al.  Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology. , 2007, The Journal of molecular diagnostics : JMD.

[60]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[61]  F. Finkelman,et al.  Differential Contribution of IL-4 and STAT6 vs STAT4 to the Development of Lupus Nephritis1 , 2003, The Journal of Immunology.

[62]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[63]  J. Duffield Macrophages in kidney repair and regeneration. , 2011, Journal of the American Society of Nephrology : JASN.

[64]  Felix Eichinger,et al.  Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy , 2006, Diabetes.

[65]  James L. Park,et al.  The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Improves Cardiometabolic Risk and Renal Inflammation in Murine Lupus1 , 2009, The Journal of Immunology.

[66]  M. Madaio,et al.  Short Term Administration of Costimulatory Blockade and Cyclophosphamide Induces Remission of Systemic Lupus Erythematosus Nephritis in NZB/W F1 Mice by a Mechanism Downstream of Renal Immune Complex Deposition1 , 2003, The Journal of Immunology.